Contract notice
Section I: Contracting
authority
I.1) Name and addresses
Medicines Discovery Catapult
Block 35, Mereside, Alderley Park
Cheshire
SK10 4ZF
UK
Contact person: Mr Kieran McGowan
Telephone: +44 1625708394
E-mail: Kieran.McGowan@md.catapult.org.uk
NUTS: UKD62
Internet address(es)
Main address: https://md.catapult.org.uk/
Address of the buyer profile: https://md.catapult.org.uk/
I.3) Communication
The procurement documents are available for unrestricted and full direct access, free of charge at:
https://procontract.due-north.com/RFx/RFxSummary?rfxId=38309d8b-362c-ec11-810e-005056b64545&projectId=e3229498-2e2c-ec11-810e-005056b64545
Additional information can be obtained from the abovementioned address
Tenders or requests to participate must be sent electronically to:
https://procontract.due-north.com/RFx/RFxSummary?rfxId=38309d8b-362c-ec11-810e-005056b64545&projectId=e3229498-2e2c-ec11-810e-005056b64545
I.4) Type of the contracting authority
Other: Drug Discovery / Health
I.5) Main activity
Other: Drug Discovery / Health
Section II: Object
II.1) Scope of the procurement
II.1.1) Title
The Supply, Delivery, Installation and Maintenance of Multimode Plate Readers (x3) and Absorbance Plate/Cuvette Readers (x2)
Reference number: DN575874
II.1.2) Main CPV code
38000000
II.1.3) Type of contract
Supplies
II.1.4) Short description
Medicines Discovery Catapult (MDC) is a national facility for collaborative R&D exploring and developing new approaches to the discovery and proof of well targeted medicines, diagnostics and biomarkers. Funded by Innovate UK, an agency of the UK government, MDC are an independent not-for-profit company bringing together a fragmented UK sector of industry, academia, charities, technologists, services, finance companies, SMEs and start-ups who together can turn good science into new, high value products. By sharing problems, rare expertise and assets we support the growth of this new community through a time of radical business and national change.
MDC wishes to create a new CL3 facility for innovative diagnostics, biomarkers and complex medicines and develop the UK’s onshore diagnostic capability and capacity and the associated supply chain. The project will create a national facility for testing and validation of new diagnostics, biomarkers and innovative therapeutics for disease.
The Validation Centre of Excellence will enable innovators to set up new companies with confidence, driving regional growth in high-value jobs and a sector of urgent national and global need. The Centre will build on the Lighthouse brand, creating a hub for new diagnostic and therapeutic validation.
This tender is for Multimode Plate Readers (x3) and Absorbance Plate/Cuvette Readers (x2), which will be used in the new facility.
II.1.5) Estimated total value
Value excluding VAT:
195 000.00
GBP
II.1.6) Information about lots
This contract is divided into lots:
No
II.2) Description
II.2.3) Place of performance
NUTS code:
UKD62
II.2.4) Description of the procurement
Medicines Discovery Catapult (MDC) is a national facility for collaborative R&D exploring and developing new approaches to the discovery and proof of well targeted medicines, diagnostics and biomarkers. Funded by Innovate UK, an agency of the UK government, MDC are an independent not-for-profit company bringing together a fragmented UK sector of industry, academia, charities, technologists, services, finance companies, SMEs and start-ups who together can turn good science into new, high value products. By sharing problems, rare expertise and assets we support the growth of this new community through a time of radical business and national change.
MDC wishes to create a new CL3 facility for innovative diagnostics, biomarkers and complex medicines and develop the UK’s onshore diagnostic capability and capacity and the associated supply chain. The project will create a national facility for testing and validation of new diagnostics, biomarkers and innovative therapeutics for disease.
The Validation Centre of Excellence will enable innovators to set up new companies with confidence, driving regional growth in high-value jobs and a sector of urgent national and global need. The Centre will build on the Lighthouse brand, creating a hub for new diagnostic and therapeutic validation.
This tender is for Multimode Plate Readers (x3) and Absorbance Plate/Cuvette Readers (x2), which will be used in the new facility.
II.2.5) Award criteria
Criteria below:
Quality criterion: Quality - all criteria are stated in the procurement documents.
/ Weighting: 70
Quality criterion: Price - all criteria are stated in the procurement documents.
/ Weighting: 30
Price
/ Weighting:
30
II.2.6) Estimated value
Value excluding VAT:
195 000.00
GBP
II.2.7) Duration of the contract, framework agreement or dynamic purchasing system
End:
31/10/2022
This contract is subject to renewal: No
II.2.9) Information about the limits on the number of candidates to be invited
II.2.10) Information about variants
Variants will be accepted:
No
II.2.11) Information about options
Options:
No
II.2.13) Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds:
No
Section IV: Procedure
IV.1) Description
IV.1.1) Type of procedure
Open procedure
IV.1.8) Information about Government Procurement Agreement (GPA)
The procurement is covered by the Government Procurement Agreement:
Yes
IV.2) Administrative information
IV.2.2) Time limit for receipt of tenders or requests to participate
Date:
15/11/2021
Local time: 12:00
IV.2.4) Languages in which tenders or requests to participate may be submitted
EN
IV.2.6) Minimum time frame during which the tenderer must maintain the tender
Duration in months: 3 (from the date stated for receipt of tender)
IV.2.7) Conditions for opening of tenders
Date:
15/11/2021
Local time: 12:05
Section VI: Complementary information
VI.1) Information about recurrence
This is a recurrent procurement:
No
VI.4) Procedures for review
VI.4.1) Review body
Medicines Discovery Catapult
Block 35, Mereside, Alderley Park
Cheshire
SK10 4ZF
UK
E-mail: Kieran.McGowan@md.catapult.org.uk
VI.5) Date of dispatch of this notice
14/10/2021